Mersana Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Mersana Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Mersana Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Mersana Therapeutics by Barclays
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $934k | 495k | 1.89 |
2024-06-30 | $750k | 373k | 2.01 |
2024-03-31 | $1.8M | 409k | 4.48 |
2023-12-31 | $352k | 152k | 2.32 |
2023-09-30 | $43k | 34k | 1.26 |
2023-06-30 | $614k | 187k | 3.29 |
2023-03-31 | $815k | 198k | 4.11 |
2022-12-31 | $1.4M | 232k | 5.86 |
2022-09-30 | $918k | 136k | 6.76 |
2022-06-30 | $157k | 34k | 4.61 |
2022-03-31 | $166k | 42k | 3.99 |
2021-12-31 | $561k | 90k | 6.23 |
2021-09-30 | $312k | 33k | 9.44 |
2021-06-30 | $778k | 57k | 13.57 |
2021-03-31 | $2.0M | 125k | 16.19 |
2020-12-31 | $549k | 21k | 26.60 |
2020-09-30 | $538k | 29k | 18.61 |
2020-06-30 | $659k | 28k | 23.41 |
2020-03-31 | $152k | 26k | 5.84 |
2019-12-31 | $248k | 43k | 5.74 |
2019-09-30 | $46k | 29k | 1.57 |
2019-06-30 | $115k | 28k | 4.06 |
2019-03-31 | $71k | 14k | 5.27 |
2018-12-31 | $18k | 4.4k | 4.10 |
2018-09-30 | $92k | 9.2k | 10.03 |
2018-06-30 | $46k | 2.6k | 17.61 |
2018-03-31 | $68k | 4.3k | 15.94 |
2017-12-31 | $13k | 801 | 16.23 |
2017-09-30 | $66k | 3.8k | 17.36 |